Rapidly progressive glomerulonephritis natural history, complications and prognosis

Jump to navigation Jump to search

Rapidly progressive glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rapidly progressive glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray Findings

CT-scan Findings

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rapidly progressive glomerulonephritis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rapidly progressive glomerulonephritis natural history, complications and prognosis

CDC on Rapidly progressive glomerulonephritis natural history, complications and prognosis

Rapidly progressive glomerulonephritis natural history, complications and prognosis in the news

Blogs on Rapidly progressive glomerulonephritis natural history, complications and prognosis

Directions to Hospitals Treating Rapidly progressive glomerulonephritis

Risk calculators and risk factors for Rapidly progressive glomerulonephritis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Jogeet Singh Sekhon, M.D. [2]

Overview

Patients with RPGN present with flu like symptoms initially and then develop nephritic syndrome with proteinuria in some cases as well. In type III RPGN, systemic features of vasculitis are present in some cases.Pulmonary symptoms are also present in Goodpastures syndrome and Churg Strauss syndrome.The prognosis is usually poor due to rapid deterioration of renal function and is dependent on age, presence of pulmonary symptoms, serum creatinine levels and presence of ANCAs.

Natural history, complications and prognosis

Natural history

  • Patients with RPGN present with initial flu like symptoms and then progress to nephritic syndrome in 2-3 months if not treated in time[1][2].
  • Symptoms include malaise, arthralgias, fever, anorexia, weight loss, haematuria, edema, hypertension and abdominal pain.
  • Patients with respiratory system involvement as in Goodpasture syndrome and Churg strauss, have symtopms of asthma, atopy and haemoptysis as well.
  • RPGN can lead to ARF when renal symptoms develop.
  • Increase in serum creatinine and fall in GFR are used to measure the severity of the disease.
  • 70-80% Patients with RPGN will progress to end stage renal disease if not treated in time.
  • Serum creatinine >4.6 mg/dl and GFR less than 50% denote end stage renal disease and requires dialysis.
  • Histopathologically, the presence of fibrous crescents indicate irreversible renal damage and poor prognosis.

Complications

Prognosis

Prognosis

  • The prognosis of rapidly progressive glomerulonephritis is poor due to rapid deterioration of kidney function in a few weeks.
  • Prognosis depends on[3][4]
    • Age
    • Serum creatinine
    • Presence of pulmonary symptoms at the onset of disease
    • Race
    • Presence of ANCA
    • Presence of fibrous cresecnts on histopathology.
  • Factors that are indicators of poor prognosis :
    • Age >60 years
    • Serum creatinine > 7.5 mg/dl.
    • Oliguric renal failure
    • Pauci immune RPGN
    • White race
    • 75 % fibrous cresecents in the glomerulus
  • 70-80% of patients with RPGN develop end stage renal disease and require dialysis for a long time and some may require kidney transplant.

References

  1. Couser WG (1988). "Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy". Am J Kidney Dis. 11 (6): 449–64. PMID 3287904.
  2. Couser WG (1998). "Pathogenesis of glomerular damage in glomerulonephritis". Nephrol Dial Transplant. 13 Suppl 1: 10–5. PMID 9507491.
  3. Zäuner I, Bach D, Braun N, Krämer BK, Fünfstück R, Helmchen U; et al. (2002). "Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis". Am J Kidney Dis. 39 (1): 28–35. doi:10.1053/ajkd.2002.29874. PMID 11774098.
  4. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N; et al. (2006). "Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement". J Am Soc Nephrol. 17 (8): 2264–74. doi:10.1681/ASN.2005080870. PMID 16825335.

Template:WH Template:WS